AbbVie Inc. Form EFFECT: Notice of effectiveness
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2020-10-16: Form EFFECT; Description Notice of effectiveness; Document xslEFFECTX01/primary_doc.xml.
- 2015-04-22: Form EFFECT; Description Notice of effectiveness; Document xslEFFECTX01/primary_doc.xml.
- 2013-07-08: Form EFFECT; Description Notice of effectiveness; Document xslEFFECTX01/primary_doc.xml.
- 2012-12-31: Form EFFECT; Description Notice of effectiveness; Document xslEFFECTX01/primary_doc.xml.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2020-10-16 | EFFECT | Notice of effectiveness | xslEFFECTX01/primary_doc.xml | |
| 2015-04-22 | EFFECT | Notice of effectiveness | xslEFFECTX01/primary_doc.xml | |
| 2013-07-08 | EFFECT | Notice of effectiveness | xslEFFECTX01/primary_doc.xml | |
| 2012-12-31 | EFFECT | Notice of effectiveness | xslEFFECTX01/primary_doc.xml |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |